Immunity to Influenza Viruses and Vaccines: 2nd Edition

Dear Colleagues,

Influenza viruses are highly prevalent pathogens transmitted by air droplets or direct contact. Vaccination is the recommended strategy for the prevention and control of influenza. Both previous influenza infections and vaccinations shape individual immunity and impact vaccine response. Immunity to influenza comprises both innate and adaptive components. To promote the development of control and prevention of influenza, we are launching a Special Issue entitled “Immunity to Influenza Viruses and Vaccines: 2nd Edition”. In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: antiviral and anti-influenza immunity, immunological responses to potential viral vaccine antigens, the delivery methods of viral vaccine antigens, studies on vaccine adjuvants related to viral vaccine development, investigations of viral vaccine strategies that aim to raise broadly neutralizing antibodies, and theoretical studies that suggest and rationalize novel types of viral vaccines or novel ways of stimulating protective antiviral immunity. We look forward to receiving your contributions.

You are welcome to read the publications in the 1st edition at “Immunity to Influenza Viruses and Vaccines” (https://www.mdpi.com/journal/vaccines/special_issues/5899754CF3).

Dr. Rongbao Gao
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.